Mortality in schizophrenia

Journal of Psychopharmacology

Volumn 25, Issue 6, 2011, Pages 846-847

  Hasnain, Mehrul ^a   Vieweg, W Victor R ^a   Mezuk, Briana ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

AGE; CARDIOVASCULAR DISEASE; COMORBIDITY; DRUG FATALITY; DRUG USE; HUMAN; HUMAN GENETICS; ISCHEMIC HEART DISEASE; LETTER; LIFE EXPECTANCY; METABOLIC DISORDER; MORTALITY; NEOPLASM; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SMOKING; CARDIOVASCULAR MORTALITY; MORTALITY RATE; MORTALITY RISK;

ANTIPSYCHOTIC AGENTS; HUMANS; LIFE EXPECTANCY; REVIEW LITERATURE AS TOPIC; SCHIZOPHRENIA;

EID: 79960496517     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111400653     Document Type: Letter

References (8)

1. Bushe CJ, Taylor M, Haukka J. Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol. 2010 ; 24 (4 Suppl). 17-25
2. De Hert M, Correll CU, Cohen D. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophr Res. 2010 ; 117: 68-74
3. Dean CE, Thuras PD. Mortality and tardive dyskinesia: long-term study using the US National Death Index. Br J Psychiatry. 2009 ; 194: 360-364
4. Enger C, Weatherby L, Reynolds RF, Glasser DB, Walker AM. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 2004 ; 192: 19-27 (Pubitemid 38101693)
5. Hasnain M, Vieweg WV, Fredrickson SK, Beatty-Brooks M, Fernandez A, Pandurangi AK. Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications. Prim Care Diabetes. 2009 ; 3: 5-15
6. Kelly DL, McMahon RP, Liu F, et al. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. J Clin Psychiatry. 2010 ; 71: 304-311
7. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. Arch Gen Psychiatry. 2007 ; 64: 242-249 (Pubitemid 46220782)
8. Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009 ; 374: 620-627